New Delhi, April 9 Glenmark Pharmaceuticals announced on Thursday that it has received final approval from the US health regulator for its generic version of progesterone vaginal inserts used in fertility treatments.The approval from the US Food and Drug Administration (USFDA) is for 100 mg...
bioequivalence
drugapproval
endometrin
fertility treatments
generic pharmaceuticals
glenmark pharmaceuticals
medical devices
north america
pharmaceutical sales
progesterone vaginal inserts
therapeutic equivalence
us food and drug administration (usfda)
us market
vaginal inserts
women's healthcare
New Delhi, April 8 Biocon Ltd announced on Wednesday that its subsidiary, Biocon Pharma Ltd, has received approval from the US health regulator for its genetically engineered version of dapagliflozin tablets, indicated for reducing blood sugar levels in adults with type 2 diabetes mellitus.The...
New Delhi, March 14 Zydus Lifesciences announced on Saturday that its innovative drug has received approval from China's National Medical Products Administration (NMPA) for its Desidustat tablets, used to treat renal anemia.The company has licensed its Desidustat tablets to a subsidiary of...
china
china medical system
chronic kidney disease
ckd
desidustat
drugapproval
greater china
healthcare
kidney failure
licensing
medical products
medicine
oxemia
patient outcomes
renal anemia
zydus lifesciences
New Delhi, February 26 Alembic Pharmaceuticals announced on Thursday that it has received approval from the US health regulator to market a generic medication for seizures.The drug company has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug...
New Delhi, February 25 Drug firm Lupin announced on Wednesday that it has received approval from the US health regulator to market a generic medication to treat seizures.The Mumbai-based firm has received approval from the USFDA for its abbreviated new drug application (ANDA) for Brivaracetam...
anda
brivaracetam
briviact
bse
drugapproval
generic medication
india
lupin
oral solution
pharmaceutical industry
pharmaceutical sales
seizures
us market
usfda